Prions: Protein Aggregation and Infectious Diseases - Physiological ...
Prions: Protein Aggregation and Infectious Diseases - Physiological ...
Prions: Protein Aggregation and Infectious Diseases - Physiological ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1144 ADRIANO AGUZZI AND ANNA MARIA CALELLA<br />
169. Gabizon R, McKinley MP, Prusiner SB. Purified prion proteins<br />
<strong>and</strong> scrapie infectivity copartition into liposomes. Proc Natl Acad<br />
Sci USA 84: 4017–4021, 1987.<br />
170. Gabriel JM, Oesch B, Kretzschmar H, Scott M, Prusiner SB.<br />
Molecular cloning of a c<strong>and</strong>idate chicken prion protein. Proc Natl<br />
Acad Sci USA 89: 9097–9101, 1992.<br />
171. Gajdusek D, Zigas V. Clinical, pathological <strong>and</strong> epidemiological<br />
study of an acute progressive degenerative disease of the central<br />
nervous system among natives of the eastern higl<strong>and</strong>s of New<br />
Guinea. Am J Med 26: 442–469, 1959.<br />
172. Gajdusek DC. Unconventional viruses <strong>and</strong> the origin <strong>and</strong> disappearance<br />
of kuru. Science 197: 943–960, 1977.<br />
173. Gajdusek DC, Zigas V. Degenerative disease of the central nervous<br />
system in New Guinea: the endemic occurrence of “kuru” in<br />
the native population. N Engl J Med 257: 974–978, 1957.<br />
174. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic <strong>and</strong><br />
familial CJD: classification <strong>and</strong> characterisation. Br Med Bull 66:<br />
213–239, 2003.<br />
175. Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E.<br />
Fatal familial insomnia <strong>and</strong> familial Creutzfeldt-Jakob disease: clinical,<br />
pathological <strong>and</strong> molecular features. Brain Pathol 5: 43–51,<br />
1995.<br />
176. Gasset M, Baldwin MA, Fletterick RJ, Prusiner SB. Perturbation<br />
of the secondary structure of the scrapie prion protein under<br />
conditions that alter infectivity. Proc Natl Acad Sci USA 90: 1–5,<br />
1993.<br />
177. Genoud N, Behrens A, Miele G, Robay D, Heppner FL,<br />
Freigang S, Aguzzi A. Disruption of Doppel prevents neurodegeneration<br />
in mice with extensive Prnp deletions. Proc Natl Acad<br />
Sci USA 101: 4198–4203, 2004.<br />
178. Genoud N, Ott D, Braun N, Prinz M, Schwarz P, Suter U,<br />
Trono D, Aguzzi A. Antiprion prophylaxis by gene transfer of a<br />
soluble prion antagonist. Am J Pathol 172: 1287–1296, 2008.<br />
179. Gerstmann J, Sträussler E, Scheinker I. über eine eigenartige<br />
hereditär-familiäre Erkrankung des Zentralnervensystems. Zugleich<br />
ein Beitrag zur Frage des vorzeitigen lokalen Alterns Z<br />
Neurol 154: 736–762, 1936.<br />
180. Ghani AC, Donnelly CA, Ferguson NM, Anderson RM. Assessment<br />
of the prevalence of vCJD through testing tonsils <strong>and</strong> appendices<br />
for abnormal prion protein. Proc Biol Sci 267: 23–29, 2000.<br />
181. Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson<br />
RM. Estimation of the number of people incubating variant<br />
CJD. Lancet 352: 1353–1354, 1998.<br />
182. Gibbons RA, Hunter GD. Nature of the scrapie agent. Nature 215:<br />
1041–1043, 1967.<br />
183. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic<br />
prion protein in sporadic Creutzfeldt-Jakob disease. N Engl<br />
J Med 349: 1812–1820, 2003.<br />
184. Glatzel M, Aguzzi A. PrP(C) expression in the peripheral nervous<br />
system is a determinant of prion neuroinvasion. J Gen Virol 81:<br />
2813–2821, 2000.<br />
185. Glatzel M, Aguzzi A. The shifting biology of prions. Brain Res<br />
Brain Res Rev 36: 241–248, 2001.<br />
186. Glatzel M, Heppner FL, Albers KM, Aguzzi A. Sympathetic<br />
innervation of lymphoreticular organs is rate limiting for prion<br />
neuroinvasion. Neuron 31: 25–34, 2001.<br />
187. Glatzel M, Ott PM, Lindner T, Gebbers JO, Gmur A, Wuest W,<br />
Huber G, Moch H, Podvinec M, Stamm B, Aguzzi A. Human<br />
prion diseases: epidemiology <strong>and</strong> integrated risk assessment. Lancet<br />
Neurol 2: 757–763, 2003.<br />
188. Glaysher BR, Mabbott NA. Role of the draining lymph node in<br />
scrapie agent transmission from the skin. Immunol Lett 109: 64–71,<br />
2007.<br />
189. Glaysher BR, Mabbott NA. Role of the GALT in scrapie agent<br />
neuroinvasion from the intestine. J Immunol 178: 3757–3766, 2007.<br />
190. Glockshuber R, Hornemann S, Billeter M, Riek R, Wider G,<br />
Wuthrich K. Prion protein structural features indicate possible<br />
relations to signal peptidases. FEBS Lett 426: 291–296, 1998.<br />
191. Gommerman JL, Browning JL. Lymphotoxin/light, lymphoid microenvironments<br />
<strong>and</strong> autoimmune disease. Nat Rev Immunol 3:<br />
642–655, 2003.<br />
192. Gommerman JL, Mackay F, Donskoy E, Meier W, Martin P,<br />
Browning JL. Manipulation of lymphoid microenvironments in<br />
Physiol Rev VOL 89 OCTOBER 2009 www.prv.org<br />
nonhuman primates by an inhibitor of the lymphotoxin pathway.<br />
J Clin Invest 110: 1359–1369, 2002.<br />
193. Goni F, Prelli F, Schreiber F, Scholtzova H, Chung E, Kascsak<br />
R, Brown DR, Sigurdsson EM, Chabalgoity JA, Wisniewski T.<br />
High titers of mucosal <strong>and</strong> systemic anti-PrP antibodies abrogate<br />
oral prion infection in mucosal-vaccinated mice. Neuroscience 153:<br />
679–686, 2008.<br />
194. Gordon WS. Advances in veterinary research. Vet Res 58: 516–520,<br />
1946.<br />
195. Gorodinsky A, Harris DA. Glycolipid-anchored proteins in neuroblastoma<br />
cells form detergent-resistant complexes without<br />
caveolin. J Cell Biol 129: 619–627, 1995.<br />
196. Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, Soto<br />
C, Telling GC. Accelerated high fidelity prion amplification within<br />
<strong>and</strong> across prion species barriers. PLoS Pathog 4: e1000139, 2008.<br />
197. Griffith JS. Self-replication <strong>and</strong> scrapie. Nature 215: 1043–1044,<br />
1967.<br />
198. Haik S, Faucheux BA, Sazdovitch V, Privat N, Kemeny JL,<br />
Perret-Liaudet A, Hauw JJ. The sympathetic nervous system is<br />
involved in variant Creutzfeldt-Jakob disease. Nat Med 9: 1121–<br />
1122, 2003.<br />
199. Hainfellner JA, Brantner Inthaler S, Cervenakova L, Brown<br />
P, Kitamoto T, Tateishi J, Diringer H, Liberski PP, Regele H,<br />
Feucht M. The original Gerstmann-Straussler-Scheinker family of<br />
Austria: divergent clinicopathological phenotypes but constant PrP<br />
genotype. Brain Pathol 5: 201–211, 1995.<br />
200. Hamir AN, Kunkle RA, Miller JM, Hall SM. Abnormal prion<br />
protein in ectopic lymphoid tissue in a kidney of an asymptomatic<br />
white-tailed deer experimentally inoculated with the agent of<br />
chronic wasting disease. Vet Pathol 43: 367–369, 2006.<br />
201. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino<br />
A, Borchelt DR, Teplow D, Hood L, Burlingame A.<br />
Asparagine-linked glycosylation of the scrapie <strong>and</strong> cellular prion<br />
proteins. Arch Biochem Biophys 274: 1–13, 1989.<br />
202. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease:<br />
progress <strong>and</strong> problems on the road to therapeutics. Science<br />
297: 353–356, 2002.<br />
203. Healy DL, Evans J. Creutzfeldt-Jakob disease after pituitary gonadotrophins.<br />
BMJ 307: 517–518, 1993.<br />
204. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P,<br />
Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR. A transmembrane<br />
form of the prion protein in neurodegenerative disease.<br />
Science 279: 827–834, 1998.<br />
205. Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB,<br />
Lingappa VR. Transmissible <strong>and</strong> genetic prion diseases share a<br />
common pathway of neurodegeneration Nature 402: 822–826, 1999.<br />
206. Heikenwalder M, Federau C, von Boehmer L, Schwarz P,<br />
Wagner M, Zeller N, Haybaeck J, Prinz M, Becher B, Aguzzi A.<br />
Germinal center B cells are dispensable in prion transport <strong>and</strong><br />
neuroinvasion. J Neuroimmunol 192: 113–123, 2007.<br />
207. Heikenwalder M, Julius C, Aguzzi A. <strong>Prions</strong> <strong>and</strong> peripheral<br />
nerves: a deadly rendezvous. J Neurosci Res 85: 2714–2725, 2007.<br />
208. Heikenwalder M, Kurrer MO, Margalith I, Kranich J, Zeller N,<br />
Haybaeck J, Polymenidou M, Matter M, Bremer J, Jackson<br />
WS, Lindquist S, Sigurdson CJ, Aguzzi A. Lymphotoxin-dependent<br />
prion replication in inflammatory stromal cells of granulomas.<br />
Immunity 29: 998–1008, 2008.<br />
209. Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner<br />
H, Akira S, Zinkernagel R, Aguzzi A. Lymphoid follicle<br />
destruction <strong>and</strong> immunosuppression after repeated CpG oligodeoxynucleotide<br />
administration. Nat Med 10: 187–192, 2004.<br />
210. Heikenwalder M, Zeller N, Seeger H, Prinz M, Klohn PC,<br />
Schwarz P, Ruddle NH, Weissmann C, Aguzzi A. Chronic lymphocytic<br />
inflammation specifies the organ tropism of prions. Science<br />
307: 1107–1110, 2005.<br />
211. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H,<br />
Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A<br />
Toll-like receptor recognizes bacterial DNA. Nature 408: 740–745,<br />
2000.<br />
212. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl<br />
JP, Aguzzi A. Transepithelial prion transport by M cells.<br />
Nat Med 7: 976–977, 2001.